秋三 熊谷
Saga Group
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by 秋三 熊谷.
Journal of Health Science | 2012
Hajnalka Nemeth; Yuko Kai; Hiroyo Kishimoto; Haruka Sasaki; Shuzo Kumagai; 裕子 甲斐; 裕代 岸本; 悠 佐々木; 秋三 熊谷
The maximal oxygen uptake (VO2max), a maximal-endurance fitness (EF) measure is associated with the metabolic syndrome (MS) in patients with impaired glucose tolerance and type 2 diabetes mellitus (type 2 DM). The contribution of submaximal EF to MS is still not known. This report describes the contribution of submaximal EF, which is characterized by the oxygen uptake corresponding to the double product-break point (VO2 at the DPBP) on the prevalence of MS in newly diagnosed type 2 DM. The subjects of this cross-sectional study were 90 Japanese male patients with newly diagnosed type 2 DM (aged 53.0 ± 11.7 years) who had not been under any intervention (pharmaco-, diet-, and exercise therapy). VO2 at the DPBP was measured by ramp exercise test. MS was defined by the NCEP-ATP III criteria modified by Japanese-specific waist circumference. The patients were classified into two groups based on their VO2 at the DPBP (Low and High). Logistic regression models were applied with the high fitness group as a reference. The results showed a correlation between VO2 at the DPBP and VO2max (r=0.28; p=0.01). The age-adjusted VO2 at the DPBP was related to MS with an odds ratio (OR) of 2.58 and 95% confidence interval (CI) of 1.07-6.25 in the Low group. The OR became non-significant after further adjustment for the visceral fat area (VFA; OR=2.03, 95% CI, 0.74-5.62 in the Low group). Similar results were observed between VO2max and the prevalence of MS. This cross-sectional analysis demonstrated that VO2 at the DPBP and VO2max contributed to the prevalence of MS, but VFA cancelled out both associations. Intervention or prospective study is needed to elucidate the relative contribution of EF or VFA to MS.
Journal of Health Science | 2004
知子 畑山; Tomoko Hatayama; 秋三 熊谷; Shuzo Kumagai
Journal of Health Science | 2012
知子 畑山; Tomoko Hatayama; 恵理 松尾; Eri Matsuo; 清英 村上; Kiyohide Murakami; 真弓 長野; Mayumi Nagano; 善彦 森山; Yoshihiko Moriyama; 秋三 熊谷; Shuzo Kumagai
Journal of Health Science | 2017
貴文 齋藤; Takafumi Saito; 正博 崎田; Masahiro Sakita; 秋三 熊谷; Shuzo Kumagai
日本臨床 | 2014
秋三 熊谷; 正博 崎田
Journal of Health Science | 2013
秋三 熊谷; 知子 畑山; 久人 西内; 裕子 戸高; Shuzo Kumagai; Tomoko Hatayama; Hisato Nishiuchi; Hiroko Todaka
Journal of Health Science | 2013
貴紀 本田; 裕歩 岸本; 幸子 山下; 秋三 熊谷; Takanori Honda; Hiro Kishimoto; Sachiko Yamashita; Shuzo Kumagai
Journal of Health Science | 2012
秋三 熊谷; 五月 古賀; 裕歩 岸本; 悠 佐々木; Shuzo Kumagai; Satsuki Koga; Hiro Kishimoto; Haruka Sasaki
アンチ・エイジング医学 | 2011
秋三 熊谷; 裕代 岸本
Journal of Health Science | 2011
茂美 高柳; 英明 福盛; 厚 一宮; 秋三 熊谷; Shigemi Takayanagi; Hideaki Fukumori; Atsushi Ichimiya; Shuzo Kumagai